S&P 500   4,549.34
DOW   36,054.43
QQQ   385.05
14 best consumer staples dividend stocks
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
Ex dividend date vs record date: What’s the difference?
How to find blue-chip dividend stocks
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
What is the consumer staples sector?
6 best online and direct marketing retail stocks to invest in
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
Last chance to set up your portfolio for OPEC cuts
What does consumer price index measure?
S&P 500   4,549.34
DOW   36,054.43
QQQ   385.05
14 best consumer staples dividend stocks
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
Ex dividend date vs record date: What’s the difference?
How to find blue-chip dividend stocks
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
What is the consumer staples sector?
6 best online and direct marketing retail stocks to invest in
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
Last chance to set up your portfolio for OPEC cuts
What does consumer price index measure?
S&P 500   4,549.34
DOW   36,054.43
QQQ   385.05
14 best consumer staples dividend stocks
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
Ex dividend date vs record date: What’s the difference?
How to find blue-chip dividend stocks
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
What is the consumer staples sector?
6 best online and direct marketing retail stocks to invest in
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
Last chance to set up your portfolio for OPEC cuts
What does consumer price index measure?
S&P 500   4,549.34
DOW   36,054.43
QQQ   385.05
14 best consumer staples dividend stocks
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
Ex dividend date vs record date: What’s the difference?
How to find blue-chip dividend stocks
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
What is the consumer staples sector?
6 best online and direct marketing retail stocks to invest in
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
Last chance to set up your portfolio for OPEC cuts
What does consumer price index measure?

Biotricity Stock Price, News & Analysis (OTCMKTS:BTCY)

$1.04
+0.05 (+5.05%)
(As of 12/6/2023 ET)
Compare
Today's Range
$0.95
▼
$1.05
50-Day Range
$0.81
▼
$2.16
52-Week Range
$0.70
▼
$5.98
Volume
22,628 shs
Average Volume
37,688 shs
Market Capitalization
$8.91 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$12.00
Stock AnalysisAnalyst ForecastsChartEarningsFinancialsHeadlinesInsider TradesOwnershipSEC Filings

BTCY stock logo

About Biotricity Stock (OTCMKTS:BTCY)

Biotricity, Inc., a medical technology company, provides biometric data monitoring solutions in the United States. The company focuses on delivery of remote monitoring solutions to medical, healthcare, and consumer markets, including diagnostic and post-diagnostic solutions for lifestyle and chronic illnesses. It offers Bioflux mobile cardiac telemetry solution, an integrated ECG device; and ECG analysis software that analyzes and synthesizes patient ECG monitoring data, as well as software components. The company is based in Redwood City, California.

BTCY Stock Price History

BTCY Stock News Headlines

November 20, 2023 | msn.com
HC Wainwright & Co. Downgrades Biotricity (BTCY)
November 14, 2023 | msn.com
Biotricity reports Q2 results
December 7, 2023 | Financial Alphas (Ad)
Lithium Discovery So BIG You Can't Miss it, Even From Space
With the green energy transition well underway, lithium demand is rapidly outpacing projected supply. While companies frantically search for new sources of this critical metal, one small company is sitting on a massive claim in North America - So big in fact that it can clearly be seen from space!
November 13, 2023 | benzinga.com
Earnings Outlook For Biotricity
November 2, 2023 | finanznachrichten.de
Biotricity, Inc.: Biotricity Releases Another Groundbreaking Product: Biotres Pro
October 31, 2023 | finance.yahoo.com
Biotricity Releases Another Groundbreaking Product: Biotres Pro
October 10, 2023 | finanznachrichten.de
Biotricity, Inc.: Biotricity Continues to Expand Patent Portfolio with Latest Patent Filing for Bioheart Device
October 10, 2023 | finance.yahoo.com
Biotricity Continues to Expand Patent Portfolio with Latest Patent Filing for Bioheart Device
December 7, 2023 | Financial Alphas (Ad)
Lithium Discovery So BIG You Can't Miss it, Even From Space
With the green energy transition well underway, lithium demand is rapidly outpacing projected supply. While companies frantically search for new sources of this critical metal, one small company is sitting on a massive claim in North America - So big in fact that it can clearly be seen from space!
October 4, 2023 | finanznachrichten.de
Biotricity, Inc.: CORRECTION BY SOURCE: Biotricity Announces Patent Filing for Cutting-Edge Biotres Device
October 4, 2023 | finance.yahoo.com
CORRECTION BY SOURCE: Biotricity Announces Patent Filing for Cutting-Edge Biotres Device
September 29, 2023 | finance.yahoo.com
Biotricity, Inc. (NASDAQ:BTCY) Could Be Riskier Than It Looks
August 28, 2023 | usatoday.com
Why Biotricity and Waqaas Al-Siddiq are Revolutionizing Modern Healthcare
August 20, 2023 | finance.yahoo.com
Biotricity, Inc. (NASDAQ:BTCY) Q1 2024 Earnings Call Transcript
August 15, 2023 | finanznachrichten.de
Biotricity, Inc.: Biotricity Reports Strong Growth for its First Quarter Fiscal Year 2024 and Provides Financial Results and Business Updates
August 15, 2023 | finance.yahoo.com
Biotricity Reports Strong Growth for its First Quarter Fiscal Year 2024 and Provides Financial Results and Business Updates
August 14, 2023 | finance.yahoo.com
Biotricity to Host First Quarter Fiscal Year 2024 Financial Results and Business Update Call on August 15th
August 11, 2023 | finanznachrichten.de
Biotricity, Inc.: Biotricity Shows Continued Growth and Strength in its Fundamentals on its Path to Profitability
August 11, 2023 | finance.yahoo.com
Biotricity Shows Continued Growth and Strength in its Fundamentals on its Path to Profitability
August 3, 2023 | msn.com
Biotricity (BTCY) Price Target Decreased by 66.67% to 4.08
July 26, 2023 | benzinga.com
Biotricity Is Paving The Way For Cardiac Health In The Age Of AI Technology
July 25, 2023 | finance.yahoo.com
Biotricity Expands Its Proprietary AI Model and Deepens Relationship with Amazon AWS and Google's Tensor Flow for Remote Cardiac Care Applications
July 23, 2023 | finanznachrichten.de
Biotricity, Inc.: Biotricity Regains Nasdaq Listing Compliance
July 21, 2023 | finance.yahoo.com
Biotricity Regains Nasdaq Listing Compliance
July 6, 2023 | finanznachrichten.de
Biotricity, Inc.: Biotricity Reports Strong Start to Fiscal Year 2024
July 6, 2023 | msn.com
HC Wainwright & Co. Reiterates Biotricity (BTCY) Buy Recommendation
July 6, 2023 | msn.com
Biotricity (BTCY) Price Target Increased by 500.00% to 12.24
See More Headlines
Receive BTCY Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Biotricity and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
11/14/2023
Today
12/07/2023
Fiscal Year End
3/31/2024
Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Industry
Medical Devices
Sub-Industry
N/A
Sector
Medical
Current Symbol
OTCMKTS:BTCY
CUSIP
N/A
CIK
1630113
Web
www.biotricity.com
Phone
(650) 832-1626
Fax
N/A
Employees
55
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$12.00
High Stock Price Target
$12.00
Low Stock Price Target
$12.00
Potential Upside/Downside
+1,053.8%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
1 Analysts

Profitability

EPS (Most Recent Fiscal Year)
($1.59)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$-18,660,000.00
Net Margins
-163.11%
Pretax Margin
-163.11%
Return on Equity
N/A
Return on Assets
-252.90%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
0.29
Quick Ratio
0.14

Sales & Book Value

Annual Sales
$11.11 million
Price / Sales
0.80
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
($2.67) per share
Price / Book
-0.39

Miscellaneous

Outstanding Shares
8,566,000
Free Float
6,963,000
Market Cap
$8.91 million
Optionable
Not Optionable
Beta
2.17
13 Stocks Institutional Investors Won't Stop Buying Cover
13 Stocks Institutional Investors Won't Stop Buying

Which stocks are major institutional investors including hedge funds and endowments buying in today's market? Click the link below and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying up as quickly as they can.

Get This Free Report

Key Executives

  • Dr. Waqaas Al-Siddiq Ph.D. (Age 38)
    Founder, President, CEO & Chairman
    Comp: $732k
  • Mr. S. John Ayanoglou (Age 56)
    Chief Financial Officer
    Comp: $305.75k
  • Mr. Andy Wong
    Vice President of Operations
  • Dr. George N. Nikopoulos
    Director of Business Development
  • Mr. Matt Zabel
    Vice President of Sales & Strategy
  • Mr. Amir Ali
    Chief Development Officer

Key Competitors

View All Competitors














BTCY Stock Analysis - Frequently Asked Questions

Should I buy or sell Biotricity stock right now?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Biotricity in the last twelve months. There are currently 1 buy rating for the stock. The consensus among Wall Street analysts is that investors should "buy" BTCY shares.
View BTCY analyst ratings or view top-rated stocks.

What is Biotricity's stock price target for 2024?

1 Wall Street analysts have issued 1-year price objectives for Biotricity's shares. Their BTCY share price targets range from $12.00 to $12.00. On average, they predict the company's stock price to reach $12.00 in the next twelve months. This suggests a possible upside of 1,053.8% from the stock's current price.
View analysts price targets for BTCY or view top-rated stocks among Wall Street analysts.

How have BTCY shares performed in 2023?

Biotricity's stock was trading at $2.6880 at the beginning of the year. Since then, BTCY stock has decreased by 61.3% and is now trading at $1.04.
View the best growth stocks for 2023 here.

How were Biotricity's earnings last quarter?

Biotricity, Inc. (OTCMKTS:BTCY) released its quarterly earnings results on Tuesday, November, 14th. The company reported ($0.44) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.34) by $0.10. The firm had revenue of $2.89 million for the quarter, compared to the consensus estimate of $3.30 million.

When did Biotricity's stock split?

Biotricity's stock reverse split on Monday, July 3rd 2023. The 1-6 reverse split was announced on Monday, July 3rd 2023. The number of shares owned by shareholders was adjusted after the closing bell on Monday, July 3rd 2023. An investor that had 100 shares of stock prior to the reverse split would have 17 shares after the split.

What other stocks do shareholders of Biotricity own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Biotricity investors own include Axsome Therapeutics (AXSM), Bank of America (BAC), Sorrento Therapeutics (SRNE), Advanced Micro Devices (AMD), Broadcom (AVGO), Cannabix Technologies (BLOZF), BioLineRx (BLRX), CV Sciences (CVSI) and Charlotte's Web (CWBHF).

How do I buy shares of Biotricity?

Shares of BTCY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

This page (OTCMKTS:BTCY) was last updated on 12/7/2023 by MarketBeat.com Staff

My Account -